APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Asthma Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Asthma Drugs Market Analysis and Forecast 2026-2032

Report ID 173967760220 December 2025194 pages

Choose your research edition.

Industry ResearchAsthma Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Asthma Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Asthma Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Asthma Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Asthma Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Asthma Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Asthma Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Asthma Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Asthma Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Asthma Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Asthma Drugs include Teva Pharmaceutical, Novartis, Merck, Roche, Pfizer, GlaxoSmithKline, AstraZeneca, Vectura Group and Boehringer Ingelheim, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Asthma Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Asthma Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Asthma Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Asthma Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Asthma Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Asthma Drugs sales, projected growth trends, production technology, application and end-user industry.

Asthma Drugs Segment by Company

Teva Pharmaceutical

Novartis

Merck

Roche

Pfizer

GlaxoSmithKline

AstraZeneca

Vectura Group

Boehringer Ingelheim

Asthma Drugs Segment by Type

Quick-relief Medications (Rescue Medications)

Medications for Allergy-induced Asthma

Asthma Drugs Segment by Application

Allergic Asthma

Non-Allergic Asthma

Asthma Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Asthma Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Asthma Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Asthma Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Asthma Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Asthma Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Quick-relief Medications (Rescue Medications) Major Manufacturers Table 3. Medications for Allergy-induced Asthma Major Manufacturers Table 4. Global Asthma Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Allergic Asthma Major Manufacturers Table 6. Non-Allergic Asthma Major Manufacturers Table 7. Asthma Drugs Industry Trends Table 8. Asthma Drugs Industry Drivers Table 9. Asthma Drugs Industry Opportunities and Challenges Table 10. Asthma Drugs Industry Restraints Table 11. Global Asthma Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Asthma Drugs Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Asthma Drugs Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Asthma Drugs Revenue Market Share by Region (2021-2026) Table 15. Global Asthma Drugs Revenue Market Share by Region (2027-2032) Table 16. Global Asthma Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Asthma Drugs Sales by Region (2021-2026) & (K Units) Table 18. Global Asthma Drugs Sales by Region (2027-2032) & (K Units) Table 19. Global Asthma Drugs Sales Market Share by Region (2021-2026) Table 20. Global Asthma Drugs Sales Market Share by Region (2027-2032) Table 21. Global Asthma Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Asthma Drugs Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Asthma Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Asthma Drugs Sales Market Share by Manufacturers (2021-2026) Table 25. Global Asthma Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Asthma Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Asthma Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Asthma Drugs Manufacturers, Product Type & Application Table 29. Global Asthma Drugs Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Asthma Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Asthma Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Asthma Drugs Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Asthma Drugs Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Asthma Drugs Revenue Market Share by Type (2021-2026) Table 36. Global Asthma Drugs Revenue Market Share by Type (2027-2032) Table 37. Global Asthma Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 39. Global Asthma Drugs Sales by Type (2027-2032) & (K Units) Table 40. Global Asthma Drugs Sales Market Share by Type (2021-2026) Table 41. Global Asthma Drugs Sales Market Share by Type (2027-2032) Table 42. Global Asthma Drugs Price by Type (2021-2026) & (US$/Unit) Table 43. Global Asthma Drugs Price by Type (2027-2032) & (US$/Unit) Table 44. Global Asthma Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Asthma Drugs Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Asthma Drugs Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Asthma Drugs Revenue Market Share by Application (2021-2026) Table 48. Global Asthma Drugs Revenue Market Share by Application (2027-2032) Table 49. Global Asthma Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 51. Global Asthma Drugs Sales by Application (2027-2032) & (K Units) Table 52. Global Asthma Drugs Sales Market Share by Application (2021-2026) Table 53. Global Asthma Drugs Sales Market Share by Application (2027-2032) Table 54. Global Asthma Drugs Price by Application (2021-2026) & (US$/Unit) Table 55. Global Asthma Drugs Price by Application (2027-2032) & (US$/Unit) Table 56. Teva Pharmaceutical Company Information Table 57. Teva Pharmaceutical Business Overview Table 58. Teva Pharmaceutical Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Teva Pharmaceutical Asthma Drugs Product Portfolio Table 60. Teva Pharmaceutical Recent Development Table 61. Novartis Company Information Table 62. Novartis Business Overview Table 63. Novartis Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Novartis Asthma Drugs Product Portfolio Table 65. Novartis Recent Development Table 66. Merck Company Information Table 67. Merck Business Overview Table 68. Merck Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Merck Asthma Drugs Product Portfolio Table 70. Merck Recent Development Table 71. Roche Company Information Table 72. Roche Business Overview Table 73. Roche Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Roche Asthma Drugs Product Portfolio Table 75. Roche Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Pfizer Asthma Drugs Product Portfolio Table 80. Pfizer Recent Development Table 81. GlaxoSmithKline Company Information Table 82. GlaxoSmithKline Business Overview Table 83. GlaxoSmithKline Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GlaxoSmithKline Asthma Drugs Product Portfolio Table 85. GlaxoSmithKline Recent Development Table 86. AstraZeneca Company Information Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. AstraZeneca Asthma Drugs Product Portfolio Table 90. AstraZeneca Recent Development Table 91. Vectura Group Company Information Table 92. Vectura Group Business Overview Table 93. Vectura Group Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Vectura Group Asthma Drugs Product Portfolio Table 95. Vectura Group Recent Development Table 96. Boehringer Ingelheim Company Information Table 97. Boehringer Ingelheim Business Overview Table 98. Boehringer Ingelheim Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Boehringer Ingelheim Asthma Drugs Product Portfolio Table 100. Boehringer Ingelheim Recent Development Table 101. North America Asthma Drugs Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Asthma Drugs Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 104. North America Asthma Drugs Sales by Type (2027-2032) & (K Units) Table 105. North America Asthma Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 106. North America Asthma Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 107. North America Asthma Drugs Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Asthma Drugs Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 110. North America Asthma Drugs Sales by Application (2027-2032) & (K Units) Table 111. North America Asthma Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 112. North America Asthma Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 113. North America Asthma Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Asthma Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. North America Asthma Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. North America Asthma Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 117. North America Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 118. North America Asthma Drugs Sales by Country (2027-2032) & (K Units) Table 119. North America Asthma Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 120. North America Asthma Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 121. United States Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 122. Canada Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 123. Europe Asthma Drugs Revenue by Type (2021-2026) & (US$ Million) Table 124. Europe Asthma Drugs Revenue by Type (2027-2032) & (US$ Million) Table 125. Europe Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 126. Europe Asthma Drugs Sales by Type (2027-2032) & (K Units) Table 127. Europe Asthma Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 128. Europe Asthma Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 129. Europe Asthma Drugs Revenue by Application (2021-2026) & (US$ Million) Table 130. Europe Asthma Drugs Revenue by Application (2027-2032) & (US$ Million) Table 131. Europe Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 132. Europe Asthma Drugs Sales by Application (2027-2032) & (K Units) Table 133. Europe Asthma Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 134. Europe Asthma Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 135. Europe Asthma Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Asthma Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. Europe Asthma Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. Europe Asthma Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 139. Europe Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 140. Europe Asthma Drugs Sales by Country (2027-2032) & (K Units) Table 141. Europe Asthma Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 142. Europe Asthma Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 143. Germany Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 144. France Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 145. U.K. Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 146. Italy Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 147. Netherlands Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 148. China Asthma Drugs Revenue by Type (2021-2026) & (US$ Million) Table 149. China Asthma Drugs Revenue by Type (2027-2032) & (US$ Million) Table 150. China Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 151. China Asthma Drugs Sales by Type (2027-2032) & (K Units) Table 152. China Asthma Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 153. China Asthma Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 154. China Asthma Drugs Revenue by Application (2021-2026) & (US$ Million) Table 155. China Asthma Drugs Revenue by Application (2027-2032) & (US$ Million) Table 156. China Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 157. China Asthma Drugs Sales by Application (2027-2032) & (K Units) Table 158. China Asthma Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 159. China Asthma Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 160. Asia Asthma Drugs Revenue by Type (2021-2026) & (US$ Million) Table 161. Asia Asthma Drugs Revenue by Type (2027-2032) & (US$ Million) Table 162. Asia Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 163. Asia Asthma Drugs Sales by Type (2027-2032) & (K Units) Table 164. Asia Asthma Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 165. Asia Asthma Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 166. Asia Asthma Drugs Revenue by Application (2021-2026) & (US$ Million) Table 167. Asia Asthma Drugs Revenue by Application (2027-2032) & (US$ Million) Table 168. Asia Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 169. Asia Asthma Drugs Sales by Application (2027-2032) & (K Units) Table 170. Asia Asthma Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 171. Asia Asthma Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 172. Asia Asthma Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Asia Asthma Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. Asia Asthma Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. Asia Asthma Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 176. Asia Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 177. Asia Asthma Drugs Sales by Country (2027-2032) & (K Units) Table 178. Asia Asthma Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 179. Asia Asthma Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 180. Japan Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 181. South Korea Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 182. India Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 183. Australia Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 184. China Taiwan Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 185. Southeast Asia Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 186. SAMEA Asthma Drugs Revenue by Type (2021-2026) & (US$ Million) Table 187. SAMEA Asthma Drugs Revenue by Type (2027-2032) & (US$ Million) Table 188. SAMEA Asthma Drugs Sales by Type (2021-2026) & (K Units) Table 189. SAMEA Asthma Drugs Sales by Type (2027-2032) & (K Units) Table 190. SAMEA Asthma Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 191. SAMEA Asthma Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 192. SAMEA Asthma Drugs Revenue by Application (2021-2026) & (US$ Million) Table 193. SAMEA Asthma Drugs Revenue by Application (2027-2032) & (US$ Million) Table 194. SAMEA Asthma Drugs Sales by Application (2021-2026) & (K Units) Table 195. SAMEA Asthma Drugs Sales by Application (2027-2032) & (K Units) Table 196. SAMEA Asthma Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 197. SAMEA Asthma Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 198. SAMEA Asthma Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. SAMEA Asthma Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 200. SAMEA Asthma Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 201. SAMEA Asthma Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 202. SAMEA Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 203. SAMEA Asthma Drugs Sales by Country (2027-2032) & (K Units) Table 204. SAMEA Asthma Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 205. SAMEA Asthma Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 206. Brazil Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 207. Argentina Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 208. Chile Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 209. Colombia Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 210. Peru Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 211. Saudi Arabia Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 212. Israel Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 213. UAE Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 214. Turkey Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 215. Iran Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 216. Egypt Asthma Drugs Revenue (2021-2032) & (US$ Million) Table 217. Key Raw Materials Table 218. Raw Materials Key Suppliers Table 219. Asthma Drugs Distributors List Table 220. Asthma Drugs Customers List Table 221. Research Programs/Design for This Report Table 222. Authors List of This Report Table 223. Secondary Sources Table 224. Primary Sources List of Figures Figure 1. Asthma Drugs Image Figure 2. Global Asthma Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Asthma Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Quick-relief Medications (Rescue Medications) Image Figure 5. Medications for Allergy-induced Asthma Image Figure 6. Global Asthma Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Asthma Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Allergic Asthma Image Figure 9. Non-Allergic Asthma Image Figure 10. Global Asthma Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Asthma Drugs Revenue (2021-2032) & (US$ Million) Figure 12. Global Asthma Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Asthma Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Asthma Drugs Revenue Market Share by Region (2021-2032) Figure 15. Global Asthma Drugs Sales (2021-2032) & (K Units) Figure 16. Global Asthma Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Asthma Drugs Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Asthma Drugs Sales YoY (2021-2032) & (K Units) Figure 19. Europe Asthma Drugs Sales YoY (2021-2032) & (K Units) Figure 20. China Asthma Drugs Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Asthma Drugs Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Asthma Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Global Asthma Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Asthma Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Asthma Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Asthma Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Asthma Drugs Revenue Market Share by Type (2021-2032) Figure 29. Global Asthma Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Asthma Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Asthma Drugs Sales Market Share by Type (2021-2032) Figure 32. Global Asthma Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Asthma Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Asthma Drugs Revenue Market Share by Application (2021-2032) Figure 35. Global Asthma Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Asthma Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Asthma Drugs Sales Market Share by Application (2021-2032) Figure 38. North America Asthma Drugs Revenue Share by Type (2021-2032) Figure 39. North America Asthma Drugs Sales Share by Type (2021-2032) Figure 40. North America Asthma Drugs Revenue Share by Application (2021-2032) Figure 41. North America Asthma Drugs Sales Share by Application (2021-2032) Figure 42. North America Asthma Drugs Revenue Share by Country (2021-2032) Figure 43. North America Asthma Drugs Sales Share by Country (2021-2032) Figure 44. Europe Asthma Drugs Revenue Share by Type (2021-2032) Figure 45. Europe Asthma Drugs Sales Share by Type (2021-2032) Figure 46. Europe Asthma Drugs Revenue Share by Application (2021-2032) Figure 47. Europe Asthma Drugs Sales Share by Application (2021-2032) Figure 48. Europe Asthma Drugs Revenue Share by Country (2021-2032) Figure 49. Europe Asthma Drugs Sales Share by Country (2021-2032) Figure 50. China Asthma Drugs Revenue Share by Type (2021-2032) Figure 51. China Asthma Drugs Sales Share by Type (2021-2032) Figure 52. China Asthma Drugs Revenue Share by Application (2021-2032) Figure 53. China Asthma Drugs Sales Share by Application (2021-2032) Figure 54. Asia Asthma Drugs Revenue Share by Type (2021-2032) Figure 55. Asia Asthma Drugs Sales Share by Type (2021-2032) Figure 56. Asia Asthma Drugs Revenue Share by Application (2021-2032) Figure 57. Asia Asthma Drugs Sales Share by Application (2021-2032) Figure 58. Asia Asthma Drugs Revenue Share by Country (2021-2032) Figure 59. Asia Asthma Drugs Sales Share by Country (2021-2032) Figure 60. SAMEA Asthma Drugs Revenue Share by Type (2021-2032) Figure 61. SAMEA Asthma Drugs Sales Share by Type (2021-2032) Figure 62. SAMEA Asthma Drugs Revenue Share by Application (2021-2032) Figure 63. SAMEA Asthma Drugs Sales Share by Application (2021-2032) Figure 64. SAMEA Asthma Drugs Revenue Share by Country (2021-2032) Figure 65. SAMEA Asthma Drugs Sales Share by Country (2021-2032) Figure 66. Asthma Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Asthma Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Quick-relief Medications (Rescue Medications)
  • Medications for Allergy-induced Asthma
Applications
  • Allergic Asthma
  • Non-Allergic Asthma
Companies covered
  • Teva Pharmaceutical
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Vectura Group
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Asthma Drugs Market by Type
  3. 1.2.1 Global Asthma Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Quick-relief Medications (Rescue Medications)
  5. 1.2.3 Medications for Allergy-induced Asthma
  6. 1.3 Asthma Drugs Market by Application
  7. 1.3.1 Global Asthma Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Allergic Asthma
  9. 1.3.3 Non-Allergic Asthma
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Asthma Drugs Market Dynamics
  1. 2.1 Asthma Drugs Industry Trends
  2. 2.2 Asthma Drugs Industry Drivers
  3. 2.3 Asthma Drugs Industry Opportunities and Challenges
  4. 2.4 Asthma Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Asthma Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Asthma Drugs Revenue by Region
  3. 3.2.1 Global Asthma Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Asthma Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Asthma Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Asthma Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Asthma Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Asthma Drugs Sales by Region
  9. 3.4.1 Global Asthma Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Asthma Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Asthma Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Asthma Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Asthma Drugs Revenue by Manufacturers
  2. 4.1.1 Global Asthma Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Asthma Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Asthma Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Asthma Drugs Sales by Manufacturers
  6. 4.2.1 Global Asthma Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Asthma Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Asthma Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Asthma Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Asthma Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Asthma Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Asthma Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Asthma Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Asthma Drugs Market CR5 and HHI
  16. 4.8.2 2025 Asthma Drugs Tier 1, Tier 2, and Tier 3
5 Asthma Drugs Market by Type
  1. 5.1 Global Asthma Drugs Revenue by Type
  2. 5.1.1 Global Asthma Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Asthma Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Asthma Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Asthma Drugs Sales by Type
  6. 5.2.1 Global Asthma Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Asthma Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Asthma Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Asthma Drugs Price by Type
6 Asthma Drugs Market by Application
  1. 6.1 Global Asthma Drugs Revenue by Application
  2. 6.1.1 Global Asthma Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Asthma Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Asthma Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Asthma Drugs Sales by Application
  6. 6.2.1 Global Asthma Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Asthma Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Asthma Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Asthma Drugs Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical
  2. 7.1.1 Teva Pharmaceutical Company Information
  3. 7.1.2 Teva Pharmaceutical Business Overview
  4. 7.1.3 Teva Pharmaceutical Asthma Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Asthma Drugs Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Asthma Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Asthma Drugs Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Asthma Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Asthma Drugs Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche Asthma Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Roche Asthma Drugs Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Asthma Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Asthma Drugs Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 GlaxoSmithKline
  32. 7.6.1 GlaxoSmithKline Company Information
  33. 7.6.2 GlaxoSmithKline Business Overview
  34. 7.6.3 GlaxoSmithKline Asthma Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 GlaxoSmithKline Asthma Drugs Product Portfolio
  36. 7.6.5 GlaxoSmithKline Recent Developments
  37. 7.7 AstraZeneca
  38. 7.7.1 AstraZeneca Company Information
  39. 7.7.2 AstraZeneca Business Overview
  40. 7.7.3 AstraZeneca Asthma Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 AstraZeneca Asthma Drugs Product Portfolio
  42. 7.7.5 AstraZeneca Recent Developments
  43. 7.8 Vectura Group
  44. 7.8.1 Vectura Group Company Information
  45. 7.8.2 Vectura Group Business Overview
  46. 7.8.3 Vectura Group Asthma Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Vectura Group Asthma Drugs Product Portfolio
  48. 7.8.5 Vectura Group Recent Developments
  49. 7.9 Boehringer Ingelheim
  50. 7.9.1 Boehringer Ingelheim Company Information
  51. 7.9.2 Boehringer Ingelheim Business Overview
  52. 7.9.3 Boehringer Ingelheim Asthma Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Boehringer Ingelheim Asthma Drugs Product Portfolio
  54. 7.9.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Asthma Drugs Market Size by Type
  2. 8.1.1 North America Asthma Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Asthma Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Asthma Drugs Price by Type (2021-2032)
  5. 8.2 North America Asthma Drugs Market Size by Application
  6. 8.2.1 North America Asthma Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Asthma Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Asthma Drugs Price by Application (2021-2032)
  9. 8.3 North America Asthma Drugs Market Size by Country
  10. 8.3.1 North America Asthma Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Asthma Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Asthma Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Asthma Drugs Market Size by Type
  2. 9.1.1 Europe Asthma Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Asthma Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Asthma Drugs Price by Type (2021-2032)
  5. 9.2 Europe Asthma Drugs Market Size by Application
  6. 9.2.1 Europe Asthma Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Asthma Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Asthma Drugs Price by Application (2021-2032)
  9. 9.3 Europe Asthma Drugs Market Size by Country
  10. 9.3.1 Europe Asthma Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Asthma Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Asthma Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Asthma Drugs Market Size by Type
  2. 10.1.1 China Asthma Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Asthma Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Asthma Drugs Price by Type (2021-2032)
  5. 10.2 China Asthma Drugs Market Size by Application
  6. 10.2.1 China Asthma Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Asthma Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Asthma Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Asthma Drugs Market Size by Type
  2. 11.1.1 Asia Asthma Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Asthma Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Asthma Drugs Price by Type (2021-2032)
  5. 11.2 Asia Asthma Drugs Market Size by Application
  6. 11.2.1 Asia Asthma Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Asthma Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Asthma Drugs Price by Application (2021-2032)
  9. 11.3 Asia Asthma Drugs Market Size by Country
  10. 11.3.1 Asia Asthma Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Asthma Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Asthma Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Asthma Drugs Market Size by Type
  2. 12.1.1 SAMEA Asthma Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Asthma Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Asthma Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Asthma Drugs Market Size by Application
  6. 12.2.1 SAMEA Asthma Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Asthma Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Asthma Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Asthma Drugs Market Size by Country
  10. 12.3.1 SAMEA Asthma Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Asthma Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Asthma Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Asthma Drugs Value Chain Analysis
  2. 13.1.1 Asthma Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Asthma Drugs Production Mode & Process
  6. 13.2 Asthma Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Asthma Drugs Distributors
  9. 13.2.3 Asthma Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst